Lightcast (Biotechnology) Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
85
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$27.1M
- Investors
-
12
Lightcast (Biotechnology) General Information
Description
Developer of a microfluidic technology designed to manipulate individual microscopic droplets encapsulating cells with flexibility. The company's technology helps to detect and automatically count the number of cells in each droplet, and the droplets can be organized to perform parallel, sequential assays with multiple readouts, enabling healthcare clients to perform workflows and allow specific droplets of interest to be dispensed while maintaining viable cells in the dispensed droplets.
Contact Information
Website
www.lightcast.bioCorporate Office
- Broers Building
- JJ Thomson Avenue
- Cambridge CB3 0FA
- England, United Kingdom
Corporate Office
- Broers Building
- JJ Thomson Avenue
- Cambridge CB3 0FA
- England, United Kingdom
Lightcast (Biotechnology) Timeline
Lightcast (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series C) | 17-Feb-2026 | $27.1M | Completed | Product In Beta Test | ||
| 4. Later Stage VC (Series B) | 26-Jul-2024 | Completed | Startup | |||
| 3. Early Stage VC (Series A) | 12-Mar-2022 | Completed | Product Development | |||
| 2. Seed Round | 30-Jun-2020 | $2.42M | $2.42M | Completed | Startup | |
| 1. University Spin-Out | 15-Feb-2019 | Completed | Startup |
Lightcast (Biotechnology) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Ordinary C | ||||||||
| Series B Preferred | ||||||||
| Series B | ||||||||
| B Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| Series A | ||||||||
| Series A | 2,387,688 | $0.000014 | $5.45 | $5.45 | 3x | $5.45 | 13.94% | |
| Ordinary | 1,028,486 | $0.000014 | $2.56 | $2.56 | 4x | $2.56 | 6.01% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Lightcast (Biotechnology) Comparisons
Industry
Financing
Details
Lightcast (Biotechnology) Competitors (8)
One of Lightcast (Biotechnology)’s 8 competitors is Deepcell, a Venture Capital-Backed company based in Menlo Park, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Deepcell | Venture Capital-Backed | Menlo Park, CA | ||||
| Immunai | Venture Capital-Backed | New York, NY | ||||
| Cytomos | Venture Capital-Backed | Edinburgh, United Kingdom | ||||
| Bruker Cellular Analysis | Private Equity-Backed | Emeryville, CA | ||||
| Samplix | Private Equity-Backed | Birkerod, Denmark |
Lightcast (Biotechnology) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lightcast (Biotechnology) Patents
Lightcast (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202507179-D0 | Improvements in or relating to a method of controling the motion of a plurality of mirco-entities | Pending | 09-May-2025 | ||
| WO-2026234383-A1 | Improvements in or relating to a method of controlling the motion of a plurality of micro-entities | Pending | 09-May-2025 | ||
| GB-202507071-D0 | Improvements in or relating to a method and a device for analysing an entity | Pending | 08-May-2025 | ||
| US-20260170429-A1 | Systems and processes for using computer algorithms for providing analytics by modeling labor markets | Pending | 13-Dec-2024 | ||
| US-20260170272-A1 | Systems and methods for tuning multilingual machine translation models | Pending | 12-Dec-2024 | G06F40/58 |
Lightcast (Biotechnology) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lightcast (Biotechnology) Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Moulton Goodies | Venture Capital | Minority | ||
| M Ventures | Corporate Venture Capital | Minority | ||
| ND Capital | Venture Capital | Minority | ||
| R&H Trust & Corporate | Corporation | Minority | ||
| Terra Magnum Capital Partners | PE/Buyout | Minority |
Lightcast (Biotechnology) FAQs
-
When was Lightcast (Biotechnology) founded?
Lightcast (Biotechnology) was founded in 2019.
-
Where is Lightcast (Biotechnology) headquartered?
Lightcast (Biotechnology) is headquartered in Cambridge, United Kingdom.
-
What is the size of Lightcast (Biotechnology)?
Lightcast (Biotechnology) has 85 total employees.
-
What industry is Lightcast (Biotechnology) in?
Lightcast (Biotechnology)’s primary industry is Biotechnology.
-
Is Lightcast (Biotechnology) a private or public company?
Lightcast (Biotechnology) is a Private company.
-
What is the current valuation of Lightcast (Biotechnology)?
The current valuation of Lightcast (Biotechnology) is .
-
What is Lightcast (Biotechnology)’s current revenue?
The current revenue for Lightcast (Biotechnology) is .
-
How much funding has Lightcast (Biotechnology) raised over time?
Lightcast (Biotechnology) has raised $119M.
-
Who are Lightcast (Biotechnology)’s investors?
Moulton Goodies, M Ventures, ND Capital, R&H Trust & Corporate, and Terra Magnum Capital Partners are 5 of 12 investors who have invested in Lightcast (Biotechnology).
-
Who are Lightcast (Biotechnology)’s competitors?
Deepcell, Immunai, Cytomos, Bruker Cellular Analysis, and Samplix are some of the 8 competitors of Lightcast (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
